Jeffrey Bonacorda
VP, Finance and Controller · KAZIA THERAPEUTICS LTD
Individual
- 2026
- Jul 8, 2026
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Jeffrey Bonacorda's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Martine A. Rothblatt - $798.23M in UTHR purchases and sales in the last 12 months
- TPG GP A, LLC - $742.97M in LFST purchases and sales in the last 12 months
- GTCR INVESTMENT XI LLC - $639.50M in SHC purchases and sales in the last 12 months
- Keith A. Meister - $591.13M in ILMN purchases and sales in the last 12 months
- Ronda E. Stryker - $580.89M in SYK purchases and sales in the last 12 months
- Mozart Aggregator II LP - $579.20M in MDLN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jeffrey Bonacorda?
Jeffrey Bonacorda is a corporate insider, tracked as VP, Finance and Controller of KAZIA THERAPEUTICS LTD (KZIA). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Jeffrey Bonacorda last file a Form 4?
The only primary Form 4 on record is dated 8 July 2026.